VANTAGEPOINT INVESTMENT ADVISERS LLC
Institutional investor · Portfolio as of Q4 2022
Top Holdings12 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ISHARES CORE S&P 500 ETF | 358,990 | $137.9M | 24.1% | $373.02 | -1.26% | 11 qtrssince 2020-Q2 | Decreased 0 |
ISHARES TR | 1.2M | $112.1M | 19.6% | $95.07 | -10.54% | 11 qtrssince 2020-Q2 | Increased 67 |
ISHARES 20 PLUS YEAR TREASURY BD | 1.1M | $107.1M | 18.7% | $92.48 | -6.82% | 3 qtrssince 2022-Q2 | Increased 85 |
ISHARES TR RUSSELL 1000 GROWTH INDEX FUND | 442,940 | $94.9M | 16.6% | $209.99 | +0.35% | 2 qtrssince 2022-Q3 | Decreased 0 |
VANGUARD GROWTH ETF | 217,050 | $46.3M | 8.1% | $34.94 | -0.19% | 2 qtrssince 2022-Q3 | Decreased 0 |
ISHARES CORE S&P MIDCAP ETF | 72,400 | $17.5M | 3.1% | $46.33 | 0.00% | 1 qtr | New 81 |
| 231,310 | $17.4M | 3.0% | — | — | 3 qtrssince 2022-Q2 | Decreased 0 | |
VANGUARD S/T CORP BOND ETF | 231,110 | $17.4M | 3.0% | $65.38 | -0.10% | 3 qtrssince 2022-Q2 | Decreased 0 |
ISHARES 1-5Y INV GRADE CORP | 172,270 | $8.6M | 1.5% | $43.14 | -0.09% | 3 qtrssince 2022-Q2 | Decreased 0 |
ISHARES RUSSELL MIDCAP INDEX FUND | 79,300 | $5.3M | 0.9% | $64.68 | 0.00% | 1 qtr | New 56 |
VANGUARD VALUE ETF | 36,300 | $5.1M | 0.9% | $121.52 | +7.57% | 3 qtrssince 2022-Q2 | Decreased 0 |
ISHARES TR RUSSELL 1000 VALUE INDEX FUND | 23,400 | $3.5M | 0.6% | $135.92 | +5.25% | 3 qtrssince 2022-Q2 | Decreased 0 |
VANTAGEPOINT INVESTMENT ADVISERS LLC manages $573.1M across 12 positions as of Q4 2022. Top holdings: IVV (24.1%), AGG (19.6%), TLT (18.7%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1.5/5.0.
Added 2 new positions, increased 2, trimmed 8. Top move: TLT (INCREASED, conviction 85). Portfolio: $573M across 12 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer